
Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
A new study finds that higher caffeine intake may decrease the risk of patients developing new onset atrial fibrillation.
Caffeine in a wide variety of forms has been ingested for centuries for both its therapeutic properties and its social leavening effects. Research has also associated caffeine with human ills ranging from anxiety disorders to cancer and GI maladies to cardiac arrhythmias. In fact, physicians and the general public alike believe caffeine consumption induces cardiac dysrhythmias. But research on the link has to date been inconclusive.
A new

